Total submissions: 5
| Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
|---|---|---|---|---|---|---|---|---|
| Illumina Laboratory Services, |
RCV001146592 | SCV001307342 | uncertain significance | Seckel syndrome 1 | 2017-09-13 | criteria provided, single submitter | clinical testing | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease. |
| Labcorp Genetics |
RCV001248833 | SCV001488299 | uncertain significance | not provided | 2022-10-13 | criteria provided, single submitter | clinical testing | This sequence change affects a donor splice site in intron 43 of the ATR gene. It is expected to disrupt RNA splicing. Variants that disrupt the donor or acceptor splice site typically lead to a loss of protein function (PMID: 16199547), and loss-of-function variants in ATR are known to be pathogenic (PMID: 21228398, 23144622). This variant is present in population databases (rs200556378, gnomAD 0.3%), including at least one homozygous and/or hemizygous individual. This variant has not been reported in the literature in individuals affected with ATR-related conditions. ClinVar contains an entry for this variant (Variation ID: 805997). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
| Ambry Genetics | RCV002382227 | SCV002670385 | likely benign | Inborn genetic diseases | 2022-09-15 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
| Fulgent Genetics, |
RCV002481759 | SCV002776019 | uncertain significance | Seckel syndrome 1; Familial cutaneous telangiectasia and oropharyngeal predisposition cancer syndrome | 2021-11-05 | criteria provided, single submitter | clinical testing | |
| Pediatric Oncology, |
RCV001248833 | SCV001147030 | uncertain significance | not provided | 2019-02-15 | no assertion criteria provided | clinical testing |